Evaluation of a novel precision template‐guided biopsy system for detecting prostate cancer
Open Access
- 5 August 2008
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 102 (5), 546-550
- https://doi.org/10.1111/j.1464-410x.2008.07832.x
Abstract
OBJECTIVE To explore the ability of a novel transrectal ultrasonography (TRUS) device (TargetScanTM, Envisioneering Medical Technologies, St. Louis MO) that creates a three‐dimensional map of the prostate and calculates an optimal biopsy scheme, to accurately sample the prostate and define the true extent of disease, as standard TRUS‐guided prostate biopsy relies on the operator to distribute the biopsy sites, often resulting in under‐ and oversampling regions of the gland. PATIENTS AND METHODS In a multicentre retrospective chart review evaluating patients who had a TargetScan prostate biopsy between January 2006 and June 2007, we determined the overall cancer detection rate in all patients and in subgroups based on prostate specific antigen level, digital rectal examination, and indication for biopsy. We assessed the pathological significance of cancer detected, defined as a Gleason score of ≥7, positive margins, extracapsular disease or >20% tumour volume in the prostatectomy specimen. We also evaluated the concordance in Gleason score between the biopsy and prostatectomy specimen. RESULTS Cancer was detected in 50 (35.7%) of the 140 patients biopsied, including 39 (47.6%) with no previous biopsies. Of 23 prostatectomy specimens, 20 (87%) had pathologically significant disease. The biopsy predicted the prostatectomy Gleason score in 12 patients (52%), overestimated in two (9%), underestimated in eight (35%), and biopsy Gleason score could not be assigned in one (4%). CONCLUSIONS Template‐guided biopsy potentially produces a higher cancer detection rate and more accurate assessment of grade. Prostatectomy specimens did not have a high rate of pathologically insignificant disease.Keywords
This publication has 21 references indexed in Scilit:
- Is There a Better Way to Biopsy the Prostate? Prospects for a Novel Transrectal Systematic Biopsy ApproachUrology, 2007
- Extended 21-Sample Needle Biopsy Protocol for Diagnosis of Prostate Cancer in 1000 Consecutive PatientsEuropean Urology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Transrectal ultrasound‐guided biopsy of prostate voxels identified as suspicious of malignancy on three‐dimensional 1H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4–10 ng/mlNMR in Biomedicine, 2006
- Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathologyJournal of Magnetic Resonance Imaging, 2006
- The Rectal Administration of Lignocaine Gel and Periprostatic Lignocaine Infiltration During Transrectal Ultrasound-Guided Prostate Biopsy Provides Effective AnalgesiaThe Annals of The Royal College of Surgeons of England, 2006
- Prostate biopsy: how many cores are enough?Urologic Oncology: Seminars and Original Investigations, 2003
- Extended Peripheral Zone Biopsy Schemes Increase Cancer Detection Rates and Minimize Variance in Prostate Specific Antigen and Age Related Cancer Rates: Results of a Community Multi-Practice StudyJournal of Urology, 2003
- OPTIMAL COMBINATIONS OF SYSTEMATIC SEXTANT AND LATERALLY DIRECTED BIOPSIES FOR THE DETECTION OF PROSTATE CANCERJournal of Urology, 2001
- A PROSPECTIVE RANDOMIZED TRIAL COMPARING 6 VERSUS 12 PROSTATE BIOPSY CORES: IMPACT ON CANCER DETECTIONJournal of Urology, 2000